| 12497457 |
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases |
Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar |
2025-12-16 |
|
| 12466897 |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
Gregory Alan Lazar |
2025-11-11 |
|
| 12448423 |
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains |
Matthew Bernett, John Desjarlais, Rajat Varma, Juan Diaz, Alex Nisthal +3 more |
2025-10-21 |
|
| 12415849 |
Heterodimeric proteins |
Matthew Bernett, Rumana Rashid, John Desjarlais |
2025-09-16 |
|
| 12378313 |
Bispecific binding agents binding to CLDN18.2 and CD3 |
Matthew Bernett, Alex Nisthal |
2025-08-05 |
|
| 12378326 |
Anti-CD28 x anti-PSMA antibodies |
John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng, Matthew Adam Dragovich +6 more |
2025-08-05 |
|
| 12365743 |
Anti-CD28 x anti-PSMA antibodies |
John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng, Matthew Adam Dragovich +6 more |
2025-07-22 |
|
| 12359002 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more |
2025-07-15 |
|
| 12152076 |
Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
Matthew Bernett, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more |
2024-11-26 |
$22,601,000 |
| 12129309 |
Heterodimeric antibodies that bind CD3 and CD38 |
Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal |
2024-10-29 |
$19,420,000 |
| 12054545 |
Heterodimeric antibodies that bind somatostatin receptor 2 |
Rumana Rashid, Sung-Hyung Lee, Paul Foster |
2024-08-06 |
$10,764,000 |
| 12006345 |
Untargeted and targeted IL-10 Fc-fusion proteins |
Rajat Varma, Yoon Kyung Kim, Rumana Rashid, Alex Nisthal, Juan Diaz +2 more |
2024-06-11 |
$14,019,000 |
| 11945880 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more |
2024-04-02 |
$13,323,000 |
| 11919958 |
Anti-CD28 compositions |
John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng |
2024-03-05 |
$7,091,000 |
| 11859011 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more |
2024-01-02 |
$5,819,000 |
| 11840579 |
Bispecific antibodies that bind to CD38 and CD3 |
Matthew Bernett, Seung Chu, John Desjarlais |
2023-12-12 |
$10,640,000 |
| 11814423 |
Heterodimeric proteins |
Matthew Bernett, Rumana Rashid, John Desjarlais |
2023-11-14 |
$8,908,000 |
| 11739145 |
Bispecific binding agents binding to CLDN18.2 and CD3 |
Matthew Bernett, Alex Nisthal |
2023-08-29 |
|
| 11718667 |
Optimized antibody variable regions |
Matthew Bernett, Rumana Rashid, John Desjarlais |
2023-08-08 |
$12,086,000 |
| 11673972 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more |
2023-06-13 |
$14,580,000 |
| 11634506 |
Heterodimeric proteins |
Matthew Bernett, Rumana Rashid, John Desjarlais |
2023-04-25 |
$15,182,000 |
| 11623957 |
Heterodimeric antibodies that bind CD3 and PSMA |
John Desjarlais, Seung Chu |
2023-04-11 |
$16,675,000 |
| 11618776 |
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains |
Matthew Bernett, John Desjarlais, Rajat Varma, Juan Diaz, Alex Nisthal +3 more |
2023-04-04 |
$8,497,000 |
| 11591401 |
Anti-CD28 compositions |
John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng |
2023-02-28 |
$17,756,000 |
| 11530274 |
Anti-STEAP1 antigen-binding protein |
Olivier Nolan-Stevaux, Cong Li, Christopher Murawsky, Benjamin M. Alba, Neeraj Jagdish Agrawal +2 more |
2022-12-20 |
$888,148,000 |
